Hong Kong Pharma Digital Technology Holdings Limited (HKPD) Balance Sheet
HKPD balance sheet, FY2026
March 31, 2026 · U.S. dollars$12.8M assets = $3.3M liabilities + $9.6M equity
Both columns are drawn to the same scale: what HKPD owns equals what it owes plus shareholders’ equity. Hover a block for its value.
HKPD financial health
Descriptive bands, not a rating. Fiscal FY2026.
HKPD balance sheet trends, FY2023–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $3.4MFY2023 | $12.8MFY2026 | +55.6%/yr | |
| Total liabilities | $2.8MFY2023 | $3.3MFY2026 | +4.9%/yr | |
| Shareholders’ equity | $585,242FY2023 | $9.6MFY2026 | +153.9%/yr | |
| Cash & short-term investments | $524,613FY2023 | $221,841FY2026 | −24.9%/yr | |
| Total debt | $691,076FY2023 | $1.3MFY2026 | +22.1%/yr | |
| Net cash (debt) | −$166,463FY2023 | −$1.0MFY2026 | −$869,860 | |
| Working capital | $198,404FY2023 | $9.1MFY2026 | +$8.9M | |
| Book value per share | $0.05FY2023 | $0.41FY2026 | +97.2%/yr | |
| Current ratio | 1.08FY2023 | 3.86FY2026 | +2.78 | |
| Debt / equity | 1.18FY2023 | 0.13FY2026 | −1.05 | |
| Shares outstanding | 11.0MFY2023 | 23.5MFY2026 | +28.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
HKPD assets
HKPD liabilities and equity
HKPD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
HKPD balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | $221,841 | $3.0M | $619,575 | $524,613 |
| Cash & equivalents | $221,841 | $748,721 | $619,575 | $524,613 |
| Short-term investments | $0 | $2.3M | $0 | — |
| Receivables | $3.8M | $4.7M | $3.7M | $1.7M |
| Inventory | $360,107 | $559,982 | $933,299 | $190,887 |
| Other current assets | $8.0M | $448,312 | $2.5M | $335,172 |
| Total current assets | $12.3M | $8.7M | $7.8M | $2.7M |
| Property, plant & equipment (net) | $434,128 | $593,734 | $833,693 | $654,261 |
| Goodwill & intangible assets | $76,643 | $96,437 | $31,825 | $4,029 |
| Long-term investments | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 |
| Total assets | $12.8M | $9.4M | $8.7M | $3.4M |
| Liabilities | ||||
| Accounts payable | $1.5M | $1.7M | $1.3M | $1.4M |
| Short-term debt | $1.2M | $864,661 | $849,701 | $419,624 |
| Deferred revenue | — | $124,507 | $191,066 | $268,028 |
| Total current liabilities | $3.2M | $2.9M | $3.2M | $2.6M |
| Long-term debt | $0 | $1.5M | $1.1M | $116,862 |
| Lease obligations | $380,260 | $499,515 | $752,340 | $511,861 |
| Other long-term liabilities | $65,275 | $6,412 | $117,836 | $154,590 |
| Total liabilities | $3.3M | $4.4M | $4.4M | $2.8M |
| Shareholders' equity | ||||
| Common stock & paid-in capital | $23,500 | $11,000 | $10,000 | $6,843 |
| Retained earnings (deficit) | $368,089 | $1.5M | $1.5M | $201,391 |
| Accumulated other comprehensive income | $240,122 | $10,819 | −$4,858 | −$4,342 |
| Total shareholders' equity | $9.6M | $5.0M | $4.3M | $585,242 |
| Key figures | ||||
| Total debt | $1.3M | $2.4M | $2.1M | $691,076 |
| Net cash (debt) | −$1.0M | $630,681 | −$1.5M | −$166,463 |
| Working capital | $9.1M | $5.8M | $4.6M | $198,404 |
| Tangible book value | $9.5M | $4.9M | $4.2M | $581,213 |
| Book value per share | $0.41 | $0.49 | — | $0.05 |
| Shares outstanding | 23.5M | 10.2M | — | 11.0M |
| Current ratio | 3.86 | 2.99 | 2.46 | 1.08 |
| Quick ratio | 1.26 | 2.65 | 1.37 | 0.87 |
| Debt / equity | 0.13 | 0.48 | 0.49 | 1.18 |
| Equity / assets | 74.6% | 53.0% | 49.1% | 17.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & short-term investments | $221,841 | $221,841 | $2.5M | $2.5M | $3.0M | $3.0M | $3.0M | $364,990 | $364,990 | $619,575 | $619,575 |
| Cash & equivalents | $221,841 | $221,841 | $190,912 | $190,912 | $748,721 | $748,721 | $748,721 | $364,990 | $364,990 | $619,575 | $619,575 |
| Short-term investments | — | $0 | $2.3M | $2.3M | $2.3M | $2.3M | — | — | — | $0 | — |
| Receivables | $3.8M | $3.8M | $5.1M | $5.1M | $4.7M | $4.7M | $4.7M | $4.9M | $4.9M | $3.7M | $3.7M |
| Inventory | $360,107 | $360,107 | $593,373 | $593,373 | $559,982 | $559,982 | $559,982 | $555,522 | $555,522 | $933,299 | $933,299 |
| Other current assets | $8.0M | $8.0M | $676,816 | $689,868 | $448,312 | $448,312 | $505,541 | $3.1M | $3.1M | $2.5M | $2.5M |
| Total current assets | $12.3M | $12.3M | $8.9M | $8.9M | $8.7M | $8.7M | $8.7M | $8.9M | $8.9M | $7.8M | $7.8M |
| Property, plant & equipment (net) | $434,128 | $434,128 | $686,080 | $686,080 | $593,734 | $593,734 | $593,734 | $1.2M | $1.2M | $833,693 | $833,693 |
| Goodwill & intangible assets | $76,643 | $76,643 | $90,218 | $90,218 | $96,437 | $96,437 | $96,437 | $89,300 | $89,299 | $31,825 | $31,825 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $12.8M | $12.8M | $9.6M | $9.6M | $9.4M | $9.4M | $9.4M | $10.2M | $10.2M | $8.7M | $8.7M |
| Liabilities | |||||||||||
| Accounts payable | $1.5M | $812,156 | $1.2M | $1.2M | $1.7M | $1.7M | $1.7M | $1.7M | $1.9M | $1.3M | $1.8M |
| Short-term debt | $1.2M | — | $808,406 | — | $864,661 | $864,661 | $864,661 | $1.1M | $1.1M | $849,701 | $849,701 |
| Deferred revenue | — | — | $529,008 | — | $124,507 | $124,507 | — | $74,877 | — | $191,066 | — |
| Total current liabilities | $3.2M | $3.2M | $3.0M | $3.0M | $2.9M | $2.9M | $2.9M | $3.6M | $3.6M | $3.2M | $3.2M |
| Long-term debt | $0 | $0 | $0 | $1.3M | $0 | $1.5M | $0 | $1.0M | $0 | $1.1M | $0 |
| Lease obligations | — | $380,260 | — | $582,653 | — | $499,515 | — | $1.1M | — | $752,340 | — |
| Other long-term liabilities | $65,275 | $65,275 | $1.5M | $129,713 | $1.5M | $6,412 | $1.5M | $200,759 | $1.2M | $117,836 | $1.2M |
| Total liabilities | $3.3M | $3.3M | $4.5M | $4.5M | $4.4M | $4.4M | $4.4M | $4.8M | $4.8M | $4.4M | $4.4M |
| Shareholders' equity | |||||||||||
| Common stock & paid-in capital | $23,500 | — | $11,000 | — | $11,000 | $11,000 | $11,000 | $10,000 | $10,000 | $10,000 | $10,000 |
| Retained earnings (deficit) | $368,089 | $368,089 | $1.7M | $1.7M | $1.5M | $1.5M | $1.5M | $2.4M | $2.4M | $1.5M | $1.5M |
| Accumulated other comprehensive income | $240,122 | — | $10,746 | — | $10,819 | $10,819 | $10,818 | $15,174 | −$34,825 | −$4,858 | −$304,857 |
| Total shareholders' equity | $9.6M | $9.6M | $5.1M | $5.1M | $5.0M | $5.0M | $5.0M | $5.4M | $5.4M | $4.3M | $4.3M |
| Key figures | |||||||||||
| Total debt | $1.3M | — | $2.3M | $1.3M | $2.4M | $2.4M | $2.4M | $2.3M | $2.3M | $2.1M | $2.1M |
| Net cash (debt) | −$1.0M | — | $208,650 | $1.1M | $630,681 | $630,681 | $630,681 | −$2.0M | −$2.0M | −$1.5M | −$1.5M |
| Working capital | $9.1M | $9.1M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | $5.3M | $5.3M | $4.6M | $4.6M |
| Tangible book value | $9.5M | $9.5M | $5.1M | $5.1M | $4.9M | $4.9M | $4.9M | $5.3M | $5.3M | $4.2M | $4.2M |
| Book value per share | $0.27 | $0.41 | $0.47 | $0.47 | $0.48 | $0.48 | $0.48 | $0.54 | $0.54 | $0.43 | — |
| Shares outstanding | 36.0M | 23.5M | 11.0M | 11.0M | 10.4M | 10.4M | 10.4M | 10.0M | 10.0M | 10.0M | — |
| Current ratio | 3.86 | 3.86 | 2.93 | 2.93 | 2.99 | 2.99 | 2.99 | 2.46 | 2.46 | 2.46 | 2.46 |
| Quick ratio | 1.26 | 1.25 | 2.51 | 2.50 | 2.65 | 2.65 | 2.63 | 1.46 | 1.46 | 1.37 | 1.36 |
| Debt / equity | 0.13 | — | 0.44 | 0.26 | 0.48 | 0.48 | 0.48 | 0.44 | 0.44 | 0.49 | 0.49 |
| Equity / assets | 74.6% | 74.6% | 53.4% | 53.4% | 53.0% | 53.0% | 53.0% | 52.7% | 52.7% | 49.1% | 49.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed August 7, 2026); data from EODHD.
HKPD financial position
At the end of fiscal 2026 (March 31, 2026), Hong Kong Pharma Digital Technology had total assets of $12.8 million (up 36.4% from a year earlier), total liabilities of $3.3 million and shareholders' equity of $9.6 million. It held $0.2 million in cash and short-term investments against $1.3 million of debt, net debt of $1.0 million. Its current ratio was 3.86. In the latest quarter (ended June 30, 2026) total assets were $12.8 million and equity $9.6 million.
Related: HKPD income statement, HKPD cash flow statement, HKPD key metrics. See the HKPD stock overview for the latest quote and news.
HKPD balance sheet FAQ
What are Hong Kong Pharma Digital Technology's total assets?
Hong Kong Pharma Digital Technology reported total assets of $12.8 million at the end of fiscal 2026 (March 31, 2026), compared with $9.4 million a year earlier.
How much debt does Hong Kong Pharma Digital Technology have?
Hong Kong Pharma Digital Technology had $1.3 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.13.
How much cash does Hong Kong Pharma Digital Technology have?
Hong Kong Pharma Digital Technology held $0.2 million in cash and short-term investments at the end of fiscal 2026; with $1.3 million of debt that is net debt of $1.0 million.
What is Hong Kong Pharma Digital Technology's book value?
Hong Kong Pharma Digital Technology's shareholders' equity (book value) was $9.6 million at the end of fiscal 2026, or $0.41 per share.
What is Hong Kong Pharma Digital Technology's current ratio?
Hong Kong Pharma Digital Technology had current assets of $12.3 million and current liabilities of $3.2 million, a current ratio of 3.86 (it can cover its short-term obligations).
How much goodwill does Hong Kong Pharma Digital Technology have?
Hong Kong Pharma Digital Technology carried $0.1 million of goodwill and intangible assets, 0.6% of total assets, at the end of fiscal 2026.